Filing Details

Accession Number:
0001859061-23-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-06 18:43:47
Reporting Period:
2023-03-31
Accepted Time:
2023-04-06 18:43:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1840439 Biomea Fusion Inc. BMEA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1859061 A2A Pharmaceuticals, Inc. 59 5Th Ave
New York NY 10003
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-31 200,000 $31.25 4,100,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. A total of 200,000 shares were sold at an average price of 31.25 in multiple transactions ranging in price from 30.87 to 31.64